J
Joyce C Kellen
Researcher at University of Calgary
Publications - 10
Citations - 5491
Joyce C Kellen is an academic researcher from University of Calgary. The author has contributed to research in topics: Atrial fibrillation & Sinus rhythm. The author has an hindex of 7, co-authored 10 publications receiving 5195 citations.
Papers
More filters
Journal ArticleDOI
A comparison of rate control and rhythm control in patients with atrial fibrillation.
D. G. Wyse,Albert L. Waldo,John P. DiMarco,Michael J. Domanski,Yves Rosenberg,Eleanor Schron,Joyce C Kellen,H L Greene,M C Mickel,J E Dalquist,Scott D. Corley +10 more
TL;DR: Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate- control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate -control strategy.
Journal ArticleDOI
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
Scott D. Corley,Andrew E. Epstein,John P. DiMarco,Michael J. Domanski,Nancy L. Geller,H. Leon Greene,Richard Josephson,Joyce C Kellen,Richard C. Klein,Andrew D. Krahn,Mary Mickel,L. Brent Mitchell,Joy Dalquist Nelson,Yves Rosenberg,Eleanor Schron,Lynn Shemanski,Albert L. Waldo,D. George Wyse,Affirm Investigators +18 more
TL;DR: An “on-treatment” analysis of the relationship of survival to cardiac rhythm and treatment as they changed over time suggests that any beneficial antiarrhythmic effects of AADs are offset by their adverse effects.
Journal ArticleDOI
Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy
Mina K. Chung,Lynn Shemanski,David Sherman,H. Leon Greene,David B. Hogan,Joyce C Kellen,Soo G. Kim,Lisa W. Martin,Yves Rosenberg,D. George Wyse,Affirm Investigators +10 more
TL;DR: The AFFIRM functional status substudy aimed to test the hypothesis that functional status is similar in rate-control and rhythm-control strategies for atrial fibrillation, and found presence of AF was associated with worse NYHA-FC.
Journal ArticleDOI
Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Anne B. Curtis,Bernard J. Gersh,Scott D. Corley,John P. DiMarco,Michael J. Domanski,Nancy L. Geller,H L Greene,Joyce C Kellen,Mary Mickel,Joy Dalquist Nelson,Yves Rosenberg,Eleanor Schron,Lynn Shemanski,Albert L. Waldo,D. G. Wyse,Affirm Investigators +15 more
TL;DR: The AFFIRM study as mentioned in this paper was a randomized multicenter comparison of two treatment strategies, rate control versus rhythm control, in high-risk patients with atrial fibrillation (AF).
Journal ArticleDOI
Effect of β-Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)
Kristin E. Ellison,Kristin E. Ellison,Gail E. Hafley,Kathleen T. Hickey,Joyce C Kellen,James Coromilas,Kenneth M. Stein,Kerry L. Lee,Alfred E. Buxton +8 more
TL;DR: Blocking agents have beneficial effects on survival of patients having characteristics of those enrolled in the MUSTT trial, and these effects do not appear to be due to a specific antiarrhythmic effect of &bgr;-blockers.